Yoshihito Kogure Selected Research

Yoshihito Kogure Research Topics

Disease

21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 10/2014
12	Neoplasms (Cancer) 12/2022 - 06/2005
6	Carcinoma (Carcinomatosis) 02/2020 - 06/2016
5	Disease Progression 02/2024 - 01/2021
5	Lung Neoplasms (Lung Cancer) 06/2023 - 04/2014
3	Pathologic Constriction (Stenosis) 01/2022 - 03/2009
2	Pneumonia (Pneumonitis) 01/2023 - 01/2018
2	Dyspnea (Shortness of Breath) 01/2022 - 04/2018
2	Respiratory Insufficiency (Respiratory Failure) 12/2021 - 07/2020
2	Febrile Neutropenia 12/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2020 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2019 - 11/2018
2	Sarcoidosis (Schaumann Disease) 01/2013 - 06/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2024
1	Thymoma (Thymic Carcinoma) 02/2024
1	Necrotizing Pneumonia 01/2024
1	Bacteremia 01/2024
1	Cough 01/2022
1	Fistula 01/2022
1	Leukopenia 12/2021
1	Neutropenia 12/2021
1	Sepsis (Septicemia) 12/2021
1	Carcinoid Tumor (Carcinoid) 10/2021
1	Hemorrhage 10/2021
1	Tracheoesophageal Fistula 01/2021
1	Tracheal Stenosis 01/2021
1	Embolism (Embolus) 07/2020
1	Circulating Neoplastic Cells 07/2020
1	Thrombosis (Thrombus) 07/2020
1	Teratoma (Teratoid Tumor) 03/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Cytokine Release Syndrome 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Malignant Pleural Effusion 04/2018
1	Fever (Fevers) 04/2018
1	Chest Pain (Chest Pains) 04/2018
1	Small Cell Carcinoma 01/2018

Drug/Important Bio-Agent (IBA)

7	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 04/2014
5	pembrolizumabIBA 02/2024 - 01/2019
5	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2015
5	Docetaxel (Taxotere)FDA Link 06/2023 - 01/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 04/2014
4	130-nm albumin-bound paclitaxelIBA 06/2023 - 01/2018
4	PlatinumIBA 01/2023 - 06/2016
4	Pemetrexed (MTA)FDA Link 01/2023 - 04/2016
3	SiliconesIBA 01/2022 - 03/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2015
2	osimertinibIBA 12/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2021 - 05/2018
2	amrubicinIBA 01/2019 - 11/2018
2	Formaldehyde (Formol)FDA Link 01/2015 - 04/2014
2	ParaffinIBA 01/2015 - 04/2014
1	Methotrexate (Mexate)FDA LinkGeneric 03/2024
1	lenvatinibIBA 02/2024
1	Panton-Valentine leukocidinIBA 01/2024
1	Meropenem (Merrem)FDA LinkGeneric 01/2024
1	Vancomycin FDA LinkGeneric 01/2024
1	Keratins (Keratin)IBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	Claudin-4IBA 01/2022
1	ChromatinIBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2020
1	LigandsIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019
1	SolventsIBA 03/2019
1	atezolizumabIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019
1	NivolumabIBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	CrizotinibIBA 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	C-Reactive ProteinIBA 04/2018
1	Talc FDA Link 04/2018
1	Investigational DrugsIBA 04/2018
1	Gemcitabine FDA Link 01/2018
1	AZD 6244IBA 01/2018

Therapy/Procedure

11	Therapeutics 06/2023 - 01/2018
8	Drug Therapy (Chemotherapy) 02/2024 - 03/2014
5	Stents 01/2022 - 03/2009
5	Bronchoscopes 07/2020 - 06/2012
1	Immunotherapy 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 11/2021
1	Chemoradiotherapy 10/2021
1	General Anesthesia 10/2021
1	Argon Plasma Coagulation 10/2021
1	Aftercare (After-Treatment) 01/2021
1	Thrombectomy 07/2020
1	Salvage Therapy 03/2019
1	Radiotherapy 01/2019
1	Pleurodesis 04/2018